LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 88

Search options

  1. Article: High-Power Short-Duration Lesion Index-Guided Posterior Wall Isolation beyond Pulmonary Vein Isolation for Persistent Atrial Fibrillation.

    Conti, Sergio / Sabatino, Francesco / Fortunato, Fabrizio / Ferrara, Giuliano / Cascino, Antonio / Sgarito, Giuseppe

    Journal of clinical medicine

    2023  Volume 12, Issue 16

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2023-08-11
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm12165228
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Extensive Posterior Wall Isolation on Top of Pulmonary Vein Isolation Guided by Ablation Index in Persistent Atrial Fibrillation Ablation.

    Sabatino, Francesco / Oriente, Domenico / Fortunato, Fabrizio / Cascino, Antonio / Ferrara, Giuliano / Sgarito, Giuseppe / Conti, Sergio

    Life (Basel, Switzerland)

    2023  Volume 13, Issue 3

    Abstract: Background: Durable pulmonary vein isolation (PVI) is recommended for symptomatic paroxysmal atrial fibrillation (AF) treatment, but it has been demonstrated that it may not be enough to treat persistent AF (Pe-AF). Therefore, posterior wall isolation ( ... ...

    Abstract Background: Durable pulmonary vein isolation (PVI) is recommended for symptomatic paroxysmal atrial fibrillation (AF) treatment, but it has been demonstrated that it may not be enough to treat persistent AF (Pe-AF). Therefore, posterior wall isolation (PWI) is among the strategies adopted on top of PVI to treat Pe-AF patients. However, PWI using contiguous and optimized radiofrequency lesions remains challenging, and few studies have evaluated the impact of the Ablation Index (AI) on the efficacy of PWI. Moreover, previous papers did not evaluate arrhythmia recurrences using continuous monitoring.
    Methods: This is a prospective, observational, single-center study on patients affected by Pe-AF undergoing treated PVI plus AI-guided PWI. Procedures were performed using the CARTO mapping system, SmartTouch SF ablation catheter, and PentaRay multipolar mapping catheter. The AI settings were 500-550 for the anterior PV aspect and roofline, while the settings were 450-500 for the posterior PV aspect, bottom line, and/or PW lesions. All patients received an implantable loop recorder (ILR). All patients underwent clinical evaluation in the outpatient clinic at 1, 3, 6, 12, 18, and 24 months. A standard 12-lead ECG was performed at each visit, and device data from the ILR were reviewed to assess for arrhythmia recurrence.
    Results: Between January 2021 and December 2021, forty-one consecutive patients underwent PVI plus PWI guided by AI at our center and were prospectively enrolled in the study. PVI was achieved in all patients, first-pass roofline block was obtained in 82.9% of the patients, and first-pass block of the bottom line was achieved in 36.5% of the patients. In 39% of the patients, PWI was not performed with a "box-only" lesion set, but with scattered lesions across the PW to achieve PWI. AI on the anterior aspect of the left PVs was 528 ± 22, while on the posterior aspect of the left PVs, it was 474 ± 18; on the anterior aspect of the right PVs, it was 532 ± 27, while on the posterior aspect of the right PVs, it was 477 ± 16; on the PW, AI was 468 ± 19. No acute complications occurred at the end of the procedure. After the blanking period, 70.7% of the patients reported no arrhythmia recurrence during the 12-month follow-up period.
    Conclusions: In patients with Pe-AF undergoing catheter ablation, PWI guided by AI seems to be an effective and feasible strategy in addition to standard PVI.
    Language English
    Publishing date 2023-03-11
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662250-6
    ISSN 2075-1729
    ISSN 2075-1729
    DOI 10.3390/life13030761
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Extensive Posterior Wall Isolation on Top of Pulmonary Vein Isolation Guided by Ablation Index in Persistent Atrial Fibrillation Ablation

    Francesco Sabatino / Domenico Oriente / Fabrizio Fortunato / Antonio Cascino / Giuliano Ferrara / Giuseppe Sgarito / Sergio Conti

    Life, Vol 13, Iss 761, p

    2023  Volume 761

    Abstract: Background: Durable pulmonary vein isolation (PVI) is recommended for symptomatic paroxysmal atrial fibrillation (AF) treatment, but it has been demonstrated that it may not be enough to treat persistent AF (Pe-AF). Therefore, posterior wall isolation ( ... ...

    Abstract Background: Durable pulmonary vein isolation (PVI) is recommended for symptomatic paroxysmal atrial fibrillation (AF) treatment, but it has been demonstrated that it may not be enough to treat persistent AF (Pe-AF). Therefore, posterior wall isolation (PWI) is among the strategies adopted on top of PVI to treat Pe-AF patients. However, PWI using contiguous and optimized radiofrequency lesions remains challenging, and few studies have evaluated the impact of the Ablation Index (AI) on the efficacy of PWI. Moreover, previous papers did not evaluate arrhythmia recurrences using continuous monitoring. Methods: This is a prospective, observational, single-center study on patients affected by Pe-AF undergoing treated PVI plus AI-guided PWI. Procedures were performed using the CARTO mapping system, SmartTouch SF ablation catheter, and PentaRay multipolar mapping catheter. The AI settings were 500–550 for the anterior PV aspect and roofline, while the settings were 450–500 for the posterior PV aspect, bottom line, and/or PW lesions. All patients received an implantable loop recorder (ILR). All patients underwent clinical evaluation in the outpatient clinic at 1, 3, 6, 12, 18, and 24 months. A standard 12-lead ECG was performed at each visit, and device data from the ILR were reviewed to assess for arrhythmia recurrence. Results: Between January 2021 and December 2021, forty-one consecutive patients underwent PVI plus PWI guided by AI at our center and were prospectively enrolled in the study. PVI was achieved in all patients, first-pass roofline block was obtained in 82.9% of the patients, and first-pass block of the bottom line was achieved in 36.5% of the patients. In 39% of the patients, PWI was not performed with a “box-only” lesion set, but with scattered lesions across the PW to achieve PWI. AI on the anterior aspect of the left PVs was 528 ± 22, while on the posterior aspect of the left PVs, it was 474 ± 18; on the anterior aspect of the right PVs, it was 532 ± 27, while on the posterior aspect of the right PVs, ...
    Keywords persistent atrial fibrillation ; atrial fibrillation ablation ; pulmonary vein isolation ; posterior wall isolation ; Ablation Index ; Science ; Q
    Subject code 616
    Language English
    Publishing date 2023-03-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Author Correction: Insights into next generation sequencing guided antibody selection strategies.

    Erasmus, M Frank / Ferrara, Fortunato / D'Angelo, Sara / Spector, Laura / Leal-Lopes, Camila / Teixeira, André A / Sørensen, Jesper / Nagpal, Suhani / Perea-Schmittle, Kathryn / Choudhary, Alok / Honnen, William / Calianese, David / Antonio Rodriguez Carnero, Luis / Cocklin, Simon / Greiff, Victor / Pinter, Abraham / Bradbury, Andrew R M

    Scientific reports

    2024  Volume 14, Issue 1, Page(s) 3090

    Language English
    Publishing date 2024-02-07
    Publishing country England
    Document type Published Erratum
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-024-53751-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Biochemical and Functional Characterization of the Three Zebrafish Transglutaminases 2.

    Lisetto, Manuel / Fattorini, Mariagiulia / Lanza, Andrea / Gerdol, Marco / Griffin, Martin / Wang, Zhuo / Ferrara, Fortunato / Sblattero, Daniele

    International journal of molecular sciences

    2023  Volume 24, Issue 15

    Abstract: Transglutaminase 2 (TG2) is a multifunctional protein widely distributed in various tissues and involved in many physiological and pathological processes. However, its actual role in biological processes is often controversial as TG2 shows different ... ...

    Abstract Transglutaminase 2 (TG2) is a multifunctional protein widely distributed in various tissues and involved in many physiological and pathological processes. However, its actual role in biological processes is often controversial as TG2 shows different effects in these processes depending on its localization, cell type, or experimental conditions. We characterized the enzymatic and functional properties of TG2 proteins expressed in Danio rerio (zebrafish) to provide the basis for using this established animal model as a reliable tool to characterize TG2 functions in vivo. We confirmed the existence of three genes orthologous to human TG2 (zTGs2) in the zebrafish genome and their expression and function during embryonic development. We produced and purified the zTGs2s as recombinant proteins and showed that, like the human enzyme, zTGs2 catalyzes a Ca
    MeSH term(s) Animals ; Humans ; Apoptosis/genetics ; Catalysis ; Cell Adhesion ; Fibroblasts ; Gene Expression ; HEK293 Cells ; Phylogeny ; Protein Conformation ; Protein Glutamine gamma Glutamyltransferase 2/chemistry ; Protein Glutamine gamma Glutamyltransferase 2/classification ; Protein Glutamine gamma Glutamyltransferase 2/genetics ; Recombinant Proteins/chemistry ; Recombinant Proteins/genetics ; Zebrafish/genetics ; Zebrafish/metabolism ; Zebrafish Proteins/chemistry ; Zebrafish Proteins/classification ; Zebrafish Proteins/genetics
    Chemical Substances Protein Glutamine gamma Glutamyltransferase 2 (EC 2.3.2.13) ; Recombinant Proteins ; TGM2 protein, human ; Zebrafish Proteins
    Language English
    Publishing date 2023-07-27
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms241512041
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Author Correction: Insights into next generation sequencing guided antibody selection strategies.

    Erasmus, M Frank / Ferrara, Fortunato / D'Angelo, Sara / Spector, Laura / Leal-Lopes, Camila / Teixeira, André A / Sørensen, Jesper / Nagpal, Suhani / Perea-Schmittle, Kathryn / Choudhary, Alok / Honnen, William / Calianese, David / Antonio Rodriguez Carnero, Luis / Cocklin, Simon / Greiff, Victor / Pinter, Abraham / Bradbury, Andrew R M

    Scientific reports

    2023  Volume 13, Issue 1, Page(s) 22616

    Language English
    Publishing date 2023-12-18
    Publishing country England
    Document type Published Erratum
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-023-49214-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: High throughput purification of monoclonal recombinant antibodies using a Protein-A coated membrane plate system.

    Leal-Lopes, Camila / D'Angelo, Sara / Erasmus, M Frank / Teixeira, Andre A R / Temples, Graham / Zhou, Jinxiang / Bradbury, Andrew R M / Ferrara, Fortunato

    New biotechnology

    2023  Volume 77, Page(s) 111–119

    Abstract: The therapeutic use of monoclonal antibodies (mAbs) ranges from cancer treatment to immune-mediated conditions, covering infectious and cardiovascular disorders, among others. The development of improved methods for therapeutic antibody discovery has ... ...

    Abstract The therapeutic use of monoclonal antibodies (mAbs) ranges from cancer treatment to immune-mediated conditions, covering infectious and cardiovascular disorders, among others. The development of improved methods for therapeutic antibody discovery has accelerated the identification of numerous mAbs: a discovery campaign can be deeply mined, resulting in hundreds, even thousands, of potential antibody leads for a given target of interest. High throughput mAb expression and purification methods are required for the rapid validation of those leads. In this work, we describe the implementation of a Protein-A coated membrane plate system, the Purexa™ AHT membrane plate, for robust preparative purification of hundreds of recombinant mAbs, without the need for automation. The high efficiency (>80%) recovery generated sufficient mAb for downstream screening analyses such as ELISA and surface plasmon resonance (SPR). This new system allows the functional validation of hundreds of lead antibodies from discovery campaigns in a timely manner regardless of operational size.
    MeSH term(s) Antibodies, Monoclonal ; Recombinant Proteins ; Staphylococcal Protein A ; Surface Plasmon Resonance ; Enzyme-Linked Immunosorbent Assay
    Chemical Substances Antibodies, Monoclonal ; Recombinant Proteins ; Staphylococcal Protein A
    Language English
    Publishing date 2023-08-28
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2400836-9
    ISSN 1876-4347 ; 1876-4347
    ISSN (online) 1876-4347
    ISSN 1876-4347
    DOI 10.1016/j.nbt.2023.08.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Determining the affinities of high-affinity antibodies using KinExA and surface plasmon resonance.

    Erasmus, M Frank / Dovner, Molly / Ferrara, Fortunato / D'Angelo, Sara / Teixeira, André A / Leal-Lopes, Camila / Spector, Laura / Hopkins, Elizabeth / Bradbury, Andrew R M

    mAbs

    2023  Volume 15, Issue 1, Page(s) 2291209

    Abstract: Accurate and efficient affinity measurement techniques are essential for the biophysical characterization of therapeutic monoclonal antibodies, one of the fastest growing drug classes. Surface plasmon resonance (SPR) is widely used for determining ... ...

    Abstract Accurate and efficient affinity measurement techniques are essential for the biophysical characterization of therapeutic monoclonal antibodies, one of the fastest growing drug classes. Surface plasmon resonance (SPR) is widely used for determining antibody affinity, but does not perform well with extremely high affinity (low picomolar to femtomolar range) molecules. In this study, we compare the SPR-based Carterra LSA and the kinetic exclusion assay (KinExA) for measuring the affinities of 48 antibodies generated against the SARS-CoV-2 receptor-binding domain. These data reveal that high-affinity antibodies can be generated straight from selections using high-quality
    MeSH term(s) Surface Plasmon Resonance/methods ; Antibodies, Monoclonal/chemistry ; Antibody Affinity
    Chemical Substances Antibodies, Monoclonal
    Language English
    Publishing date 2023-12-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2537838-7
    ISSN 1942-0870 ; 1942-0870
    ISSN (online) 1942-0870
    ISSN 1942-0870
    DOI 10.1080/19420862.2023.2291209
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction.

    Correale, Michele / Mazzeo, Pietro / Tricarico, Lucia / Croella, Francesca / Fortunato, Martino / Magnesa, Michele / Amatruda, Marco / Alfieri, Simona / Ferrara, Salvatore / Ceci, Vincenzo / Dattilo, Giuseppe / Mele, Marco / Iacoviello, Massimo / Brunetti, Natale Daniele

    Clinical drug investigation

    2022  Volume 42, Issue 7, Page(s) 567–579

    Abstract: Cardiac remodelling is an adverse phenomenon linked to heart failure progression and an important contributor to heart failure severity. Cardiac remodelling could represent the real therapeutic goal in the treatment of patients with heart failure with ... ...

    Abstract Cardiac remodelling is an adverse phenomenon linked to heart failure progression and an important contributor to heart failure severity. Cardiac remodelling could represent the real therapeutic goal in the treatment of patients with heart failure with reduced ejection fraction, being potentially reversed through different pharmacotherapies. Currently, there are well-established drugs such as angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers and β-blockers with anti-remodelling effects; recently, angiotensin receptor neprilysin inhibitor effects on inhibiting cardiac remodelling (improving N-terminal pro-B-type natriuretic peptide levels, echocardiographic parameters of reverse cardiac remodelling and right ventricular function in patients with heart failure with reduced ejection fraction) were demonstrated. More recently, hemodynamic consequences of gliflozins, reduced cardiac hydrostatic pressure as a possible cause of ventricular remodelling and hypertrophy were proposed to explain potential anti-remodelling effects of gliflozins. Gliflozins exert their cardioprotective effects by attenuating myofibroblast activity and collagen-mediated remodelling. Another postulated mechanism is represented by the reduction in sympathetic activity, through the reduction in renal afferent nervous activity and the suppression of central reflex mechanisms. Benefits of gliflozins on left ventricular hypertrophy, dilation, and systolic and diastolic function were also described. In this review, we aimed to provide a wide overview on cardiac remodelling with a particular focus on possible anti-remodelling effects of angiotensin receptor neprilysin inhibitors and gliflozins.
    MeSH term(s) Angiotensin Receptor Antagonists/pharmacology ; Angiotensin Receptor Antagonists/therapeutic use ; Heart Failure/drug therapy ; Humans ; Neprilysin/pharmacology ; Neprilysin/therapeutic use ; Receptors, Angiotensin/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Stroke Volume ; Ventricular Remodeling
    Chemical Substances Angiotensin Receptor Antagonists ; Receptors, Angiotensin ; Sodium-Glucose Transporter 2 Inhibitors ; Neprilysin (EC 3.4.24.11)
    Language English
    Publishing date 2022-06-20
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 1220136-4
    ISSN 1179-1918 ; 0114-2402 ; 1173-2563
    ISSN (online) 1179-1918
    ISSN 0114-2402 ; 1173-2563
    DOI 10.1007/s40261-022-01166-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Primer Design and Inverse PCR on Yeast Display Antibody Selection Outputs.

    Ferrara, Fortunato / Bradbury, Andrew R M / D'Angelo, Sara

    Methods in molecular biology (Clifton, N.J.)

    2018  Volume 1721, Page(s) 35–45

    Abstract: The display of antibodies on the surface of Saccharomyces cerevisiae cells enables the high-throughput and precise selection of specific binders for the target antigen. The recent implementation of next-generation sequencing (NGS) to antibody display ... ...

    Abstract The display of antibodies on the surface of Saccharomyces cerevisiae cells enables the high-throughput and precise selection of specific binders for the target antigen. The recent implementation of next-generation sequencing (NGS) to antibody display screening provides a complete picture of the entire selected polyclonal population. As such, NGS overcomes the limitations of random clones screening, but it comes with two main limitations: (1) depending upon the platform, the sequencing is usually restricted to the variable heavy chain domain complementary determining region 3 (HCDR3), or VH gene, and does not provide additional information on the rest of the antibody gene, including the VL; and (2) the sequence-identified clones are not physically available for validation. Here, we describe a rapid and effective protocol based on an inverse-PCR method to recover specific antibody clones based on their HCDR3 sequence from a yeast display selection output.
    MeSH term(s) Complementarity Determining Regions/genetics ; DNA Primers/genetics ; Gene Library ; High-Throughput Nucleotide Sequencing ; Polymerase Chain Reaction/methods ; Saccharomyces cerevisiae/genetics ; Single-Chain Antibodies/genetics
    Chemical Substances Complementarity Determining Regions ; DNA Primers ; Single-Chain Antibodies
    Language English
    Publishing date 2018-02-08
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-4939-7546-4_4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top